000 01285nam a2200289Ia 4500
001 ebr10392231
003 CaPaEBR
006 m u
007 cr cn|||||||||
008 090311s2009 ua a sb 000 0 eng d
020 _z9789290216490
040 _aCaPaEBR
_cCaPaEBR
035 _a(OCoLC)672029515
050 1 4 _aHD9672.J6
_bM43 2009eb
245 0 0 _aMeasuring transparency to improve good governance in the public pharmaceutical sector.
_pJordan
_h[electronic resource].
246 3 _aJordan
260 _aCairo, Egypt :
_bWorld Health Organization, Regional Office for the Eastern Mediterranean,
_cc2009.
300 _a68 p. :
_bill. (some col.)
504 _aIncludes bibliographical references.
533 _aElectronic reproduction.
_bPalo Alto, Calif. :
_cebrary,
_d2013.
_nAvailable via World Wide Web.
_nAccess may be limited to ebrary affiliated libraries.
650 0 _aPharmaceutical industry
_xStandards
_zJordan.
650 0 _aPharmaceutical policy
_zJordan.
655 7 _aElectronic books.
_2local
710 2 _aWorld Health Organization.
_bRegional Office for the Eastern Mediterranean.
710 2 _aebrary, Inc.
856 4 0 _uhttp://site.ebrary.com/lib/welingkar/Doc?id=10392231
_zAn electronic book accessible through the World Wide Web; click to view
999 _c78729
_d78729